Takeda Pharmaceutical  Limited logo

Takeda Pharmaceutical Limited

TKPHF | OTC
Chart Builder DCF Calculator
$38
$0 (0.00%)
Sep 21, 2026, 4:00 PM ET · Market open

Market Data

Market Cap
$60.46B
Enterprise Value
$12.79T
Beta
0.09
Average Volume
N/A
Shares Outstanding (Diluted)
1.59B
Shares Change YoY
-0.06%
Institutional Ownership
N/A
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
0.3%
Price Change 3M
25.9%
Price Change 6M
11.6%
Price Change YTD
23.3%
Price Change 1Y
34.8%
Price Change 3Y
20.1%
Price Change 5Y
12.6%
1M CAGR (ann.)
5.9%
1Y CAGR (ann.)
40.5%
5Y CAGR (ann.)
7.2%
All-Time CAGR
1.5%

Valuation

PE Ratio
66.81
Forward PE
47.46
PEG Ratio
1.70
Forward PEG
0.87
PS Ratio
2.01
Forward PS
2.00
PB Ratio
1.27
P/FCF Ratio
11.49
P/Adj. FCF Ratio
12.69
P/OCF Ratio
9.91
EV/Sales
2.86
EV/EBIT
34.21
EV/EBITDA
11.24
EV/FCF
16.29
Earnings Yield
1.4%
FCF Yield
8.2%
Adj. FCF Yield
7.5%

Financial Health

Net Debt
¥4.09T
Total Debt
¥4.51T
Cash & Short-Term Investments
¥419.18B
Total Assets
¥14T
Current Ratio
1.14
Quick Ratio
0.62
Debt / Equity Ratio
0.65
Debt / EBITDA
3.96
Debt / FCF
5.74
OCF / Debt
0.24
Interest Coverage
1.55
Altman Z-Score
1.29
Piotroski F-Score
8

Margins & Profitability

Gross Profit Margin
62.1%
Operating Profit Margin
8.1%
EBITDA Margin
27.2%
Net Profit Margin
3.9%
FCF Margin
17.5%
Adj. FCF Margin
15.9%
SBC / Revenue
1.2%
SBC Impact (per share)
-9.4%

Returns

Return on Assets
1.1%
Return on Equity
2.4%
Return on Invested Capital
2.4%
Return on Capital Employed
3.8%
Return on Tangible Assets
2.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
7.7%
Revenue CAGR 5Y
6.7%
Revenue CAGR 10Y
9.5%
EPS CAGR 3Y
-12.3%
EPS CAGR 5Y
4.7%
EPS CAGR 10Y
-4.9%
FCF CAGR 3Y
-0.5%
FCF CAGR 5Y
10.4%
FCF CAGR 10Y
22.3%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
41.1%
Revenue Growth Next 3Y
3.5%
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
$0
EPS Growth Est (next Q)
-656.0%
Revenue Est (next Q)
$46.76M
Revenue Growth Est (next Q)
-2.0%

Fair Value Estimates

Graham Number
$21.12
Graham Upside
-44.4%
Lynch Fair Value
$2.84
Lynch Upside
-92.5%
Price Target
N/A
Price Target Upside
N/A

Cash Flow

Operating Cash Flow
¥1.1T
Free Cash Flow
¥785.41B
Adj. Free Cash Flow
¥711.39B
FCF Per Share
$448.15
OCF Per Share
$572.70
OCF/S Ratio
19.4%

Income Statement

Revenue
¥4.48T
Gross Profit
¥2.9T
Operating Income
¥360.82B
EBITDA
¥1.14T
Net Income
¥136.92B
EPS (Diluted)
$84.93
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

Dividends

Annual Dividend
$1.30
Dividend Yield
3.42%
Payout Ratio
1.5%
FCF Payout Ratio
39.4%
Adj. FCF Payout Ratio
43.5%
Dividend Growth (YoY)
-1.6%
Pay Frequency
Semi-Annual
Ex-Dividend Date
Mar 29, 2027

© 2026 bestshares.com. All rights reserved.